1. Home
  2. NRXP vs BGSF Comparison

NRXP vs BGSF Comparison

Compare NRXP & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • BGSF
  • Stock Information
  • Founded
  • NRXP 2015
  • BGSF 2007
  • Country
  • NRXP United States
  • BGSF United States
  • Employees
  • NRXP N/A
  • BGSF N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • BGSF Professional Services
  • Sector
  • NRXP Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • NRXP 58.5M
  • BGSF 63.6M
  • IPO Year
  • NRXP N/A
  • BGSF N/A
  • Fundamental
  • Price
  • NRXP $2.89
  • BGSF $5.78
  • Analyst Decision
  • NRXP Strong Buy
  • BGSF Strong Buy
  • Analyst Count
  • NRXP 4
  • BGSF 1
  • Target Price
  • NRXP $28.50
  • BGSF $9.00
  • AVG Volume (30 Days)
  • NRXP 283.3K
  • BGSF 32.2K
  • Earning Date
  • NRXP 08-19-2025
  • BGSF 08-06-2025
  • Dividend Yield
  • NRXP N/A
  • BGSF N/A
  • EPS Growth
  • NRXP N/A
  • BGSF N/A
  • EPS
  • NRXP N/A
  • BGSF N/A
  • Revenue
  • NRXP N/A
  • BGSF $266,615,000.00
  • Revenue This Year
  • NRXP N/A
  • BGSF N/A
  • Revenue Next Year
  • NRXP $230.95
  • BGSF N/A
  • P/E Ratio
  • NRXP N/A
  • BGSF N/A
  • Revenue Growth
  • NRXP N/A
  • BGSF 28.60
  • 52 Week Low
  • NRXP $1.10
  • BGSF $2.91
  • 52 Week High
  • NRXP $6.01
  • BGSF $9.06
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 54.48
  • BGSF 44.58
  • Support Level
  • NRXP $2.30
  • BGSF $5.60
  • Resistance Level
  • NRXP $2.68
  • BGSF $6.10
  • Average True Range (ATR)
  • NRXP 0.19
  • BGSF 0.40
  • MACD
  • NRXP 0.02
  • BGSF -0.10
  • Stochastic Oscillator
  • NRXP 89.39
  • BGSF 16.27

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

Share on Social Networks: